GLENMARK GENERICS INC., USA - Trademark Details
Status: 710 - Cancelled - Section 8
Serial Number
77401451
Registration Number
3998465
Word Mark
GLENMARK GENERICS INC., USA
Status
710 - Cancelled - Section 8
Status Date
2022-01-21
Filing Date
2008-02-20
Registration Number
3998465
Registration Date
2011-07-19
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2009-01-27
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
WATSON, JULIE A
Statements
Disclaimer with Predetermined Text
"GENERICS INC., USA"
Goods and Services
Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparation for the relief of pain; Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations
Pseudo Mark
GLEN MARK GENERICS INC., USA
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
2 - Sec. 8 - Entire Registration
Class Status Date
2022-01-21
Primary Code
005
First Use Anywhere Date
2008-04-01
First Use In Commerce Date
2008-04-01
Correspondences
Name
Hany W. Rizkalla
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 3146215 |
Trademark Events
Event Date | Event Description |
2008-02-26 | NEW APPLICATION ENTERED IN TRAM |
2008-02-27 | NOTICE OF PSEUDO MARK MAILED |
2008-06-02 | ASSIGNED TO EXAMINER |
2008-06-02 | NON-FINAL ACTION WRITTEN |
2008-06-02 | NON-FINAL ACTION E-MAILED |
2008-06-02 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2008-12-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2008-12-15 | ASSIGNED TO LIE |
2008-12-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-12-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2008-12-16 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2008-12-22 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2009-01-07 | NOTICE OF PUBLICATION |
2009-01-27 | PUBLISHED FOR OPPOSITION |
2009-04-21 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2009-11-23 | ABANDONMENT - NO USE STATEMENT FILED |
2009-11-23 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
2009-12-01 | TEAS PETITION TO REVIVE RECEIVED |
2009-12-01 | PETITION TO REVIVE-GRANTED |
2009-12-01 | EXTENSION RECEIVED WITH TEAS PETITION |
2010-02-01 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2009-12-01 | PETITION TO REVIVE-RECEIVED |
2010-02-02 | ASSIGNED TO PETITION STAFF |
2010-02-02 | INCOMPLETE PETITION NOTICE MAILED |
2010-02-24 | PETITION GRANTED - EXTENSION REQUEST FILED |
2009-10-21 | EXTENSION 1 FILED |
2010-03-01 | EXTENSION 1 GRANTED |
2010-05-19 | TEAS PETITION TO REVIVE RECEIVED |
2010-05-19 | PETITION TO REVIVE-GRANTED |
2010-05-19 | EXTENSION RECEIVED WITH TEAS PETITION |
2010-04-21 | EXTENSION 2 FILED |
2010-05-20 | EXTENSION 2 GRANTED |
2010-05-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2010-10-26 | TEAS PETITION TO REVIVE RECEIVED |
2010-10-26 | PETITION TO REVIVE-GRANTED |
2010-10-26 | EXTENSION RECEIVED WITH TEAS PETITION |
2010-10-21 | EXTENSION 3 FILED |
2010-10-27 | EXTENSION 3 GRANTED |
2010-10-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2011-05-23 | ABANDONMENT - NO USE STATEMENT FILED |
2011-05-23 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
2011-06-07 | TEAS PETITION TO REVIVE RECEIVED |
2011-06-07 | PETITION TO REVIVE-GRANTED |
2011-06-07 | EXTENSION RECEIVED WITH TEAS PETITION |
2011-06-07 | TEAS STATEMENT OF USE RECEIVED |
2011-04-21 | EXTENSION 4 FILED |
2011-06-09 | EXTENSION 4 GRANTED |
2011-06-07 | USE AMENDMENT FILED |
2011-06-09 | STATEMENT OF USE PROCESSING COMPLETE |
2011-06-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2011-06-10 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2011-06-15 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
2011-06-16 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2011-07-19 | REGISTERED-PRINCIPAL REGISTER |
2017-07-14 | TEAS SECTION 8 RECEIVED |
2017-08-23 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2017-09-05 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
2017-09-05 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
2020-07-19 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2022-01-21 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |